期刊文献+

异丙托溴胺联合痰热清治疗慢性阻塞性肺疾病的临床观察 被引量:1

Observation on Clinical Curative Effect of SCH 1000 Combined with Tanreqing on COPD
原文传递
导出
摘要 目的 观察异丙托溴胺联合痰热清治疗慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)的临床疗效。方法 将96例COPD患者随机分为两组,对照组给予异丙托溴胺气雾剂治疗,治疗组在对照治疗基础上联合痰热清注射液治疗。结果 治疗组总有效率为68.75%,对照组为43.75%,两组总有效率比较,差异有统计学意义(P〈0.05)。结论 异丙托溴胺联合痰热清治疗COPD有效。 Objective To observe the clinical curative effect of SCH 1000 combined with Tanreqing on chronic obstructive pulmonary diseases(COPD). Methods 96 patients with COPD were randomly recruited into a control group and a treatment group. The control group was treated with SCH 1000 aerosol and the treatment group was treated with SCH 1000 aerosol combined with Tanreqing injection. Results The treatment group had better clinical curative effects than the control group, with (P〈0.05) . Conclusion The treatment of SCH 1000 combined with Tanreqing on COPD is effective.
作者 魏铭 刘莉
出处 《国际中医中药杂志》 2009年第3期237-237,共1页 International Journal of Traditional Chinese Medicine
关键词 慢性阻塞性肺疾病 异丙托溴胺 痰热清 Chronic obstructive pulmonary diseases SCH 1000 Tanreqing
  • 相关文献

参考文献2

二级参考文献21

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 3GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 4Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 5Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
  • 6冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 7Vincken W,van Noord JA,Greefhorst AP.,et al.Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium[J].Eur Respir J,2002,19(2):209 -216.
  • 8Tashkin DP.The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease:how long-term studies contribute to our understanding[J].Am J Med,2006,119 (10 Suppl 1):63-72.
  • 9Donohue JF,van Noord JA,Bateman ED,et al.A 6-month,placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol[J].Chest,2002,122(1):47-55.
  • 10Tashkin DP,Cooper CB.The role of long-acting bronchodilators in the management of stable COPD[J].Chest,2004,125 (1):249 -259.

共引文献8247

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部